GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Days Sales Outstanding

TCM Biotech International (ROCO:4169) Days Sales Outstanding : 82.05 (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Days Sales Outstanding?

TCM Biotech International's average Accounts Receivable for the six months ended in Dec. 2023 was NT$226.8 Mil. TCM Biotech International's Revenue for the six months ended in Dec. 2023 was NT$504.4 Mil. Hence, TCM Biotech International's Days Sales Outstanding for the six months ended in Dec. 2023 was 82.05.

The historical rank and industry rank for TCM Biotech International's Days Sales Outstanding or its related term are showing as below:

ROCO:4169' s Days Sales Outstanding Range Over the Past 10 Years
Min: 69.07   Med: 83.61   Max: 107.48
Current: 82.59

During the past 13 years, TCM Biotech International's highest Days Sales Outstanding was 107.48. The lowest was 69.07. And the median was 83.61.

ROCO:4169's Days Sales Outstanding is ranked worse than
56.75% of 881 companies
in the Biotechnology industry
Industry Median: 72.67 vs ROCO:4169: 82.59

TCM Biotech International's Days Sales Outstanding increased from Dec. 2022 (79.27) to Dec. 2023 (82.05).


TCM Biotech International Days Sales Outstanding Historical Data

The historical data trend for TCM Biotech International's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Days Sales Outstanding Chart

TCM Biotech International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102.96 71.52 82.64 85.23 82.27

TCM Biotech International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85.75 82.80 79.27 83.52 82.05

Competitive Comparison of TCM Biotech International's Days Sales Outstanding

For the Biotechnology subindustry, TCM Biotech International's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TCM Biotech International's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TCM Biotech International's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where TCM Biotech International's Days Sales Outstanding falls into.



TCM Biotech International Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

TCM Biotech International's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (204.701 + 232.395) / 2 ) / 969.619*365
=218.548 / 969.619*365
=82.27

TCM Biotech International's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (221.13 + 232.395) / 2 ) / 504.385*365 / 2
=226.7625 / 504.385*365 / 2
=82.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TCM Biotech International  (ROCO:4169) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


TCM Biotech International Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


TCM Biotech International (ROCO:4169) Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines